Yoichi Hiasa

Ehime University — Japan

Medicine · Health Sciences

59h-index17.5kcitations799works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(314), Hepatocellular Carcinoma Treatment and Prognosis(201), Hepatitis C virus research(146), Liver Disease and Transplantation(114), Hepatitis B Virus Studies(108)

Publications789 total

Fibrotic MASH resolutionVCTE index to diagnose fibrotic MASH resolution and predict LREs: A global multicenter study
Med·2025
Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable Classification
Cancer Medicine·2025Open Access
Predictive value of subharmonic-aided pressure estimation for diagnosing clinically significant portal hypertension
Scientific Reports·2025Open Access
Factors associated with ulcerative colitis with non-anemic iron deficiency
BMC Gastroenterology·2025Open Access
Endoscopic closure after endoscopic submucosal dissection using novel hooking attachment with a knotting chain shaped thread system
Endoscopy·2025Open Access
Effect of remnant cholesterol on the onset of diabetes mellitus
Journal of Diabetes Investigation·2025Open Access
Effect of body mass index change on the development of diabetes mellitus
Endocrine Journal·2025Open Access
Employment Status of Patients With Liver Disease: A Nationwide Questionnaire Survey in Japan
Hepatology Research·2025· 1 citedOpen Access
GPAM upregulation enhances hepatic fat deposition and reduces visceral adipose tissue in response to trans-fatty acids
Journal of Gastroenterology·2025
An unusual pancreatic tumor with prominent calcification in a middle-aged man: what is the diagnosis?
Clinical Endoscopy·2025Open Access
Evaluation of operator variability and technical accuracy of automatic image-based registration in liver fusion imaging
Journal of Medical Ultrasonics·2025
Clinical Utility of a Prognostic Scoring System Based on <scp>LDH</scp> and <scp>CRP</scp> in <scp>HCC</scp> Patients Receiving Atezolizumab Plus Bevacizumab
Liver International·2025
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus Elimination
Hepatology Research·2025· 3 cited
Efficacy and Safety of Durvalumab Plus Tremelimumab in Hepatocellular Carcinoma Patients With Portal Vein Thrombosis and High Tumor Burden: A Multicenter Retrospective Analysis
Hepatology Research·2025
Effect of planned preoperative oral care implemented at least 2 weeks before surgery on postoperative infections: A single-center retrospective observational study
PLoS ONE·2025Open Access
Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD
Journal of Hepatology·2025· 19 cited
Potential role of Geriatric Nutritional Risk Index as a risk factor for immune-mediated adverse events during durvalumab plus tremelimumab therapy in unresectable hepatocellular carcinoma
Journal of Gastroenterology·2025· 1 cited
Development of a Neural Network to Detect Hepatic Steatosis in Metabolic Dysfunction–Associated Steatotic Liver Disease
Gastro Hep Advances·2025· 1 citedOpen Access
Limited Prognostic Impact of Sustained Virologic Response on Atezolizumab plus Bevacizumab Therapy for HCV-Related Unresectable Hepatocellular Carcinoma
Oncology·2025
Safety and Efficacy of Durvalumab Plus Tremelimumab in Older Individuals With Unresectable Hepatocellular Carcinoma: A Multicenter Analysis
Hepatology Research·2025· 1 cited
page 1 of 40Next →

Frequent Co-authors

Masashi Hirooka(26), Atsushi Hiraoka(18), Kojiro Michitaka(17), Morikazu Onji(15), Takashi Kumada(15), Hironori Ochi(15), Toru Ishikawa(15), Hidenori Toyoda(15), Koichi Takaguchi(14), Kazuto Tajiri(13), Toshifumi Tada(13), Masanori Abe(13), Yohei Koizumi(13), Bunzo Matsuura(12), Kunihiko Tsuji(12), Ei Itobayashi(12), Kazuya Kariyama(12), Kazuhiro Nouso(12), Kouji Joko(12), Noritomo Shimada(11)